$1.5M sweet spot round size
Most of their 48 investments are in rounds between $14M and $39M
2005
Mogrify raised $10M on October 2, 2023
Investors: Ahren Innovation Capital, Parkwalk Advisors and Astellas Venture Capital L.L.C.
Avilar Therapeutics raised $15M on February 16, 2023
Investors: Sanofi Ventures, RA Capital Management, L.P., Medical Excellence Capital, LLC and Astellas Venture Capital L.L.C.
NeoPhore Ltd raised $7.4M on January 19, 2023
Investors: SIXTH ELEMENT CAPITAL LLP, 3B Future Health Fund, Claris Ventures SGR SpA and Astellas Venture Capital L.L.C.
Casma Therapeutics raised $46M on November 15, 2022
Investors: Eventide Management Partners, Schroders Capital, The Column Group, Eisai Asia, Mirae Asset MAPS Global Investments Co., Ltd, Third Rock Ventures and Astellas Venture Capital L.L.C.
DEM Biopharma, Inc. raised $70M on June 23, 2022
Investors: UTokyo Innovation Platform Co., Ltd., Longwood Fund, Insight Partners, Alta Partners, Emerson Collective and Astellas Venture Capital L.L.C.
Carbon Biosciences raised $38M on June 21, 2022
Investors: Longwood Fund, Camford Capital, UTokyo Innovation Platform Co., Ltd., Solasta Ventures, Agent Capital and Astellas Venture Capital L.L.C.
Turn Biotechnologies raised undisclosed on April 11, 2022
Investors: Khosla Ventures, Shanda Group, ThreeD Capital Inc., Formic Ventures, LongeVC, HanAll BioPharma Co., Ltd, Methuselah Fund and Astellas Venture Capital L.L.C.
Mogrify raised $17M on May 4, 2021
Investors: Parkwalk Advisors, 24Haymarket and Astellas Venture Capital L.L.C.
Undisclosed raised $45M on March 23, 2021
Investors: XtalPi Inc., Parkwalk Advisors, Morningside Venture Capital 晨兴资本, o2h ventures and Astellas Venture Capital L.L.C.
NeoPhore Ltd raised $21M on March 9, 2021
Investors: SIXTH ELEMENT CAPITAL LLP, 3B Future Health Fund, 2invest financial, Claris Ventures SGR SpA and Astellas Venture Capital L.L.C.